Patients with ovarian cancer usually present with advanced disease, and the disease is
generally managed with surgical resection followed by platinum-based chemotherapy …

The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers
are diagnosed only after they have metastasized throughout the body. Effective, accurate …

Objective To present an update of the European Group on Tumor Markers guidelines for
serum markers in epithelial ovarian cancer. Methods Systematic literature survey from 2008 …

Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

CA125 is an ovarian cancer antigen that is the basis for a widely used serum assay for the
monitoring of patients with ovarian cancer; however, detailed information on its biochemical …

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer, in part
because of the lack of effective early detection methods. Although alterations of several …

Background High-grade serous ovarian and endometrial cancers are the most lethal female
reproductive tract malignancies worldwide. In part, failure to treat these two aggressive …

Cancer is one of the major public health issues in the world. It has become the second
leading cause of death, with approximately 75% of cancer deaths transpiring in low-or …

CA125 is the gold standard tumor marker in ovarian cancer. Serum level of CA125 is used to
monitor response to chemotherapy, relapse, and disease progression in ovarian cancer …

Breast cancer (BC) is the second most common cancer among women, comprising 34% of
all cancers, affecting∼ 2.23 million women every year globally. Therefore, early diagnosis of …